Merck & Co., Inc: Non-alcoholic Fatty Liver Disease trials
The registry lists 11 Non-alcoholic Fatty Liver Disease studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 3Phase 2 7No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)CompletedNCT06482112Phase 2Results posted
- A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)CompletedNCT06052566Phase 1Results posted
- DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic SteatohepatitisCompletedNCT05415722Phase 2Results posted
- A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)CompletedNCT04944992Phase 2Results posted
- AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic SteatohepatitisCompletedNCT04897594Phase 1Results posted
- A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)TerminatedNCT04583423Phase 2Results posted
- LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)CompletedNCT04328077Phase 2Results posted
- Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)CompletedNCT01431521Phase 1Results posted
- A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)CompletedNCT06465186Phase 2
- A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)CompletedNCT05877547Phase 2
- Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)CompletedNCT01110577